Diffusion Pharmaceuticals Inc.
DFFN
$0.41
Change (1 day)
$14.37
Year High
$4.14
Year Low
Categories
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.
Stock split history for Diffusion Pharmaceuticals Inc. (DFFN)
Diffusion Pharmaceuticals Inc. stock (symbol: DFFN) underwent a total of 6 stock splits.
The most recent stock split occured on Aug 17, 2023.
Annual Revenue
| Date | Splite | Multiple |
|---|---|---|
| 2023-08-17 | 2:3 | 2 |
| 2022-04-19 | 1:50 | 1 |
| 2018-12-14 | 1:15 | 1 |
| 2016-08-19 | 1:10 | 1 |
| 2014-03-10 | 1:100 | 1 |
| 2005-08-03 | 1:400 | 1 |